Graphics chip titan Nvidia Corporation (NASDAQ: NVDA) is expected to ring in a blowout quarter when it reports third-quarter results Wednesday, according to an analyst at Raymond James.
It's Monday on PreMarket Prep Plus, so that means another segment of “Briefing With Brent.”
Brent Slava has been the head of the Benzinga Pro newsdesk since 2013 and has helped investors big and small,navigate the financial markets through their ups and downs.
The COVID-19 pandemic has been a business-changing event for the restaurant industry and food-related businesses. With the reopening trade providing a lift to some businesses, food stocks could be under watch this week with some that saw business boosts during the pandemic and some that had harder times all reporting quarterly earnings.
Nvidia, Inc. (NASDAQ: NVDA) shares rallied strongly Thursday, helping the graphics chipmaker add close to $100 billion in market capitalization in a single session.
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes.
PDUFA dates are key binary events for biotech stocks that can move the needle in a big way. These are the dates by which the Food and Drug Administration is required to announce its decision regarding approvability/non-approvability of drugs.
The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals.
SPAC merger votes can act as a catalyst, as the votes complete the last step in the merger process and change the company over to a new name and ticker that can help build recognition.